So Eric H. L. purchased $1.1M of HELP
So Eric H. L. (Executive Chair) purchased 95,000 shares of CYBIN INC. (HELP) at $11.80 ($1.12M total) on 2026-09-01.
How this was made
The 30-second read
Why it matters
The purchase adds to the insider's already sizable holding, reinforcing confidence in the company's strategy.
Market read
Large insider buy may attract short‑term buying interest and support the stock price.
What to watch
Potential upcoming clinical trial data or regulatory milestones not disclosed could be driving the purchase.
Background
Form 4 filings are primary disclosures of insider transactions required by the SEC.
Ticker impact
Executive Chair So Eric H. L. purchased 95,000 shares of Cybin Inc. (HELP) for $1.12M, increasing his stake to over 4.2 million shares.
Potential short‑term upside as market digests the large insider purchase.
The purchase size ($1.1M) is material for a mid‑cap biotech and the buyer holds a senior executive role, indicating strong insider conviction.
Market effects
May boost sentiment toward biotech and pharma stocks as insider confidence is perceived positively.
Limited to U.S. biotech sector; no broader regional effect.
Minimal global impact beyond investors tracking Cybin.
Counterpoint
Insider buying could be a routine portfolio rebalancing rather than a bullish signal.
Key entities
- CompanyCybin Inc.
Biopharmaceutical company developing psychedelic therapeutics.
- ExecutiveSo Eric H. L.
Executive Chair of Cybin Inc.
